The U.S. FTC has sought more information on Novo Nordisk (NOVOb.CO) parent's $16.5 billion bid for contract drug manufacturer Catalent (CTLT.N), weeks after an application to the regulator was refiled for approval of the deal.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,